Macprox DP 250 Tablet is a combination medication containing Naproxen 250 mg and Domperidone 10 mg, formulated to provide effective relief from pain and associated gastrointestinal discomfort. Naproxen, a nonsteroidal anti-inflammatory drug (NSAID), exerts its therapeutic effect by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins responsible for inflammation, pain, and fever. This makes Macprox DP 250 suitable for managing conditions such as musculoskeletal pain, arthritis, and dysmenorrhea. Domperidone, a dopamine D2 receptor antagonist, enhances gastrointestinal motility and acts as an antiemetic, preventing nausea and vomiting that may occur as side effects of NSAID therapy or underlying conditions. The combination ensures improved patient compliance by addressing both pain and gastrointestinal symptoms simultaneously. Macprox DP 250 should be used under medical supervision, with caution advised in patients with a history of gastrointestinal ulcers, bleeding disorders, cardiac conditions, or hypersensitivity to either component. It is contraindicated in patients with known hypersensitivity to NSAIDs or domperidone, and in those with prolactin-releasing pituitary tumors. Common adverse effects may include gastrointestinal discomfort, headache, dizziness, and rarely, cardiac arrhythmias. Patients are advised to adhere to prescribed dosages and report any unusual symptoms promptly.